Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Current Assets

The latest current assets for GZPHF is $64B as of June 2026. That compares with $58B in the prior-year period — up 10.6% year over year. Investors often review this figure alongside Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, GZPHF's current assets moved from $58B to $64B — a 10.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's operating scale or balance-sheet position.

A current assets figure of $64B for GZPHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GZPHF's current assets ($64B), review year-over-year change from $58B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.